• Recipharm partners with Sato to manufacture product for Japanese market

    Mar 21, 2017, 13:28 PM by Michael Croft
    KARLSKOGA, SWEDEN - Mar 21, 2017 - Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co
    Full story
  • Eurofins to invest millions in new UK facility

    Mar 21, 2017, 13:26 PM by Michael Croft
    LIVINGSTON, SCOTLAND - Mar 21, 2017 - Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing, has announced plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland as part of a £4 million investment
    Full story
  • Human Longevity Launches Whole Genome Product, MassMutual Partnerships

    Mar 20, 2017, 12:45 PM by Michael Croft

    Bio-IT World | Human Longevity, Inc. and Massachusetts Mutual Life Insurance Co. announced an agreement to offer HLI's new whole genome sequencing product, HLIQ Whole Genome, to eligible MassMutual customers, employees, and financial professionals at a reduced price.

    Full story
  • Nvidia And Bosch Team Up On Self-Driving Car AI Supercomputer

    Mar 17, 2017, 10:35 AM by Michael Croft
    TechCrunch | Nvidia's new partner in bringing AI-powered self-driving tech to the masses definitely has the experience needed to go truly mass-market - it's Bosch.
    Full story
  • Recipharm names 2016 International Environmental Award winner

    Mar 16, 2017, 12:58 PM by Michael Croft
    STOCKHOLM, SWEDEN - Mar 16, 2017 - Recipharm has announced that its 2016 International Environmental Award has been presented to Alistair Boxall, Professor in environmental science at the University of York, for his research into the impact of chemical contaminants on the environment and human health
    Full story
  • Trump Administration Proposes Big Cuts In Medical Research Shots - Health News

    Mar 16, 2017, 11:40 AM by Michael Croft
    NPR.org | The National Institutes of Health, which funds research in treatments and cures, could lose 20 percent of its budget under the administration's proposal. More money would go for addiction treatment.
    Full story
  • MR Solutions introduces 9.4T preclinical MRI imaging solution to cardiovascular sector

    Mar 16, 2017, 09:29 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Mar 16, 2017 - MR Solutions’ new 9.4 tesla cryogen free preclinical scanners created great interest from cardiologists at the 20th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR)
    Full story
  • MDI Biological Laboratory to Offer Signature Course in Comparative Regenerative Biology

    Mar 15, 2017, 17:17 PM by Michael Croft
    BAR HARBOR, ME - Mar 15, 2017 - Why are some animals able to regenerate the form and function of almost any body part? What are the similarities and differences in the genetic circuits for regeneration in these animals? To what extent do humans share these genetic circuits? How can we manipulate these circuits in humans to trigger regeneration of lost or damaged tissues and organs?These are some of the intriguing questions that will be addressed in the MDI Biological Laboratory’s  “REGEN 2017” course in Comparative Regenerative Biology July 29 through Aug
    Full story
  • Allergan And Editas Medicine Enter Into R&D Alliance

    Mar 15, 2017, 14:25 PM by Michael Croft

    Bio-IT World Brief | Allergan and Editas Medicine have announced that they have entered into a strategic research and development alliance under which Allergan will receive exclusive access and the option to license up to five of Editas Medicine’s genome-editing ocular programs.

    Full story
  • The Pistoia Alliance Tackles Laboratory Safety with the Launch of the Chemical Safety Library Service

    Mar 15, 2017, 12:16 PM by Michael Croft
    - Mar 15, 2017 - The Pistoia Alliance Tackles Laboratory Safety with the Launch of the Chemical Safety Library ServiceCollaborative database of previously inaccessible hazardous chemical reactions improves safety for scientists carrying out experiments in the labBoston, 15 March, 2017 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, has today announced the launch of the Chemical Safety Library (CSL) Service, which allows hazardous reaction information to be captured, stored and shared, to improve laboratory safety
    Full story
  • Oxford Nanopore Announces New Sequencing System, Certification Program

    Mar 15, 2017, 08:30 AM by Michael Croft

    Bio-IT World Brief | Oxford Nanopore announced the launch of the GridION X5 today, a new system that can drive up to five MinION Flow Cells and process all the data produced within a single benchtop device.

    Full story
  • Deep 6 AI Wins Enterprise and Smart Data Category at SXSW Accelerator Competition

    Mar 14, 2017, 17:26 PM by Michael Croft
    PASADENA, CA - Mar 14, 2017 - Deep 6 AI, an artificial intelligence-enabled technology platform for matching patients to clinical trials, took home first prize in the Enterprise and Smart Data category at the 9th annual SXSW Accelerator competition, the marquee event of the South by Southwest® (SXSW®) Conference and Festivals (March 10-19, 2017)  Startup Village®
    Full story
  • MDI Biological Laboratory Completes New Center for Science Entrepreneurship

    Mar 14, 2017, 14:37 PM by Michael Croft
    BAR HARBOR, ME - Mar 14, 2017 -               Center Inaugurated with New Course on 'Bridging Disciplines' BAR HARBOR, MAINE -- The MDI Biological Laboratory inaugurates its Center for Science Entrepreneurship this week with a new course that will help University of Maine and College of the Atlantic science and engineering undergraduates explore approaches to biomedical research using concepts and tools that promote collaboration across disciplines
    Full story
  • twoXAR Announces Preclinical Proof-of-Concept Data on Novel Liver Cancer Candidate

    Mar 14, 2017, 12:47 PM by Michael Croft
    PALO ALTO, CA - Mar 14, 2017 - twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, today announced that its candidate targeting hepatocellular carcinoma (HCC or Liver Cancer), TXR-311, has shown positive results in cell-based assays
    Full story
  • IDBS extends validated service to the cloud

    Mar 14, 2017, 12:36 PM by Michael Croft
    BOSTON, US, & GUILDFORD, UNITED KINGDOM - Mar 14, 2017 - After The E-WorkBook Cloud launch earlier this year, IDBS has now enhanced its capabilities by adding a pre-qualified service to the suite, which has been designed to help organizations streamline their compliance processes for good practice (GxP) regulated systems
    Full story
  • GWAS Study Identifies Variant In African Populations Tied To Obesity

    Mar 14, 2017, 10:10 AM by Michael Croft
    Bio-IT World Brief | An international team of researchers has conducted the first study of its kind to look at the genomic underpinnings of obesity in continental Africans and African Americans.
    Full story
  • Qatar Genome Programme Launches Research Consortium

    Mar 13, 2017, 17:25 PM by Michael Croft

    Bio-IT World Brief | More than 90 genomics researchers gathered recently for the launch of the Qatar Genome Programme’s research consortium (QGPRC). The consortium is the latest step in QGP’s precision medicine implementation efforts.

    Full story
  • NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing

    Mar 13, 2017, 10:51 AM by Michael Croft
    FORT MYERS, FL, UNITED STATES - Mar 13, 2017 - NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful diagnostics, today announced that they have expanded their alliance to develop and automate the analysis of new biomarker assays for clinical trials and routine clinical testing
    Full story
  • Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed?

    Mar 13, 2017, 10:42 AM by Michael Croft
    Xconomy | This seems to be a watershed year for CAR-T therapy. The field's first-ever regulatory approval is looking like a strong possibility. However, the supercharged T cells remain an enigma.
    Full story
  • Precision NanoSystems unveils innovative system for scale-up manufacture of nanomedicines

    Mar 13, 2017, 10:31 AM by Michael Croft
    VANCOUVER, BC, CANADA - Mar 13, 2017 - Precision NanoSystems has launched the NanoAssemblr™ Scale-Up system to support the clinical development of nanomedicines
    Full story